HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Home high-flow nasal therapy in a patient with pleuroparenchymal fibroelastosis: A case report.

Abstract
A 62-year-old man with pleuroparenchymal fibroelastosis (PPFE), who had been under observation for 19 years, was admitted due to headache, fatigue, and dyspnea. Although no acute findings were detected, his symptoms were attributed to hypercapnia and exertional hypoxemia. He had a history of pneumothorax, but chose not to undergo positive airway pressure ventilation. Consequently, home high-flow nasal therapy (HFNT) was initiated, and 4 months later, he observed an improvement in his quality of life, body weight gain, and relief from hypercapnia. These outcomes suggested that home HFNT holds potential for improving the quality of life for patients with PPFE.
AuthorsKazuhiko Iwasaki, Satoshi Watanabe, Akihito Okazaki, Seiji Yano
JournalRespiratory investigation (Respir Investig) Vol. 61 Issue 6 Pg. 729-732 (Nov 2023) ISSN: 2212-5353 [Electronic] Netherlands
PMID37708638 (Publication Type: Case Reports)
CopyrightCopyright © 2023 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.
Topics
  • Male
  • Humans
  • Middle Aged
  • Hypercapnia (complications)
  • Quality of Life
  • Pneumothorax (etiology)
  • Dyspnea (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: